Brianna Perry, PA
Dermatology · New London, CTNPI 1578214706
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.3% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,958, more than ten times the $26 reported in 2023. That places this record below the midpoint for dermatology clinicians in CT, where the typical reported total is $3,198.
Across 115 payments — averaging $27.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$655
- UCB, Inc.$530
- Johnson & Johnson$458
- Incyte Corporation$445
- Lilly USA, LLC$197
- Amgen$136
- plus $778 from 16 others
What the payments were for
- Food & beverage$3,01694%
- Education$1826%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $655 |
| UCB, Inc. | 13 | $530 |
| Johnson & Johnson | 12 | $458 |
| Incyte Corporation | 14 | $445 |
| Lilly USA, LLC | 9 | $197 |
| Amgen | 7 | $136 |
| Galderma Laboratories, L.p. | 4 | $106 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Verrica Pharmaceuticals Inc. | 4 | $93 |
| LEO Pharma Inc. | 4 | $74 |
| Regeneron Healthcare Solutions, Inc. | 2 | $49 |
| Organon | 2 | $47 |
| Boehringer Ingelheim | 2 | $44 |
| Sun Pharmaceutical Industries Inc. | 2 | $40 |
| Arcutis Biotherapeutics, Inc. | 2 | $39 |
| Blueprint Medicines Corporation | 1 | $39 |
| Janssen Scientific Affairs, LLC | 1 | $32 |
| Pfizer | 1 | $29 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| Sanofi | 1 | $21 |
| Mayne Pharma Commercial LLC | 1 | $20 |
| Novartis | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,198 in reported general payments places this provider in the 50th percentile of 222 dermatology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 15 | $547 |
| Ketoconazole | 18 | $175 |
| Triamcinolone Acetonide | 14 | $100 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New London
- Mohsin MalikNew London$16K
- Michael PayetteCromwell$3.2M
- Bruce StroberCromwell$2.9M
- Brett KingFairfield$2.5M
- Mona ShahriariCromwell$2.2M
- Jeremy MossMadison$2M
- Brittany CraiglowFairfield$1.9M
- Meagen McCuskerEnfield$1.8M
- Marcus McFerrenOrange$872K
- Christopher BunickNew Haven$661K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.